Related Experiment Videos
Pentazocine and codeine: effects on human performance and mood and interactions with diazepam
Summary
This study found that while codeine and pentazocine alone did not impair performance, they altered subjective experiences. Combined with diazepam, opioid analgesics did not significantly worsen objective performance but did lead to overestimations of ability.
Area of Science:
- Pharmacology
- Neuroscience
- Human Performance
Background:
- Opioid analgesics and benzodiazepines are commonly prescribed medications.
- Understanding their combined effects on cognitive and psychomotor performance is crucial for patient safety.
- Interactions between different drug classes can lead to unpredictable outcomes.
Purpose of the Study:
- To investigate the effects of codeine and pentazocine on performance in healthy students.
- To examine the interactions between these opioid analgesics and diazepam.
- To assess subjective and objective measures of drug-induced impairment.
Main Methods:
- Double-blind, cross-over study in ten healthy students.
- Administration of placebo, codeine (100 mg), or pentazocine (75 mg) followed by diazepam (0.25 mg/kg).
- Objective performance tests and subjective visual analogue scales were used; naloxone was administered as an antagonist.
Main Results:
- Codeine and pentazocine alone did not significantly affect objective performance but altered subjective states.
- Diazepam impaired performance; interactions with opioids were minimal in objective tests, except for increased nystagmus.
- Codeine appeared to reduce diazepam absorption, and both opioids subjectively counteracted diazepam's effects, leading to overestimations of performance.
Conclusions:
- Opioid analgesics codeine and pentazocine have limited impact on objective performance when administered alone.
- Interactions with diazepam primarily manifest as subjective alterations and overestimations of performance, rather than significant objective impairment.
- Codeine may affect diazepam absorption, highlighting potential pharmacokinetic interactions.